CTLA4 and colitis: In mouse studies, a probiotic blend containing four Bifidobacterium species was found to lower systemic inflammatory cytokine levels and alleviate colitis caused by anti-CTLA4 treatment and dextran sodium sulfate (DSS).(Wang et al., 2018).